Susan Altschuller, Chief Financial Officer at Cerevel Therapeutics Holdings, Inc. (CERE), sold 27,616 shares at $41.42 ($1.1M) on 2023-12-20, disclosed to the SEC on 2023-12-21.
Open-market sale of $1.1M CERE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.42 | 13,808 | $572K | 50.0% |
| 2 | $41.42 | 13,808 | $572K | 50.0% |
| Total | $41.42 avg | 27,616 | $1.1M | 100% |